Jason Amello, SVP, CFO & Treasurer at Akebia Therapeutics, Inc. (AKBA), bought 4,000 shares at $17.00 ($68K) on 2014-03-25, disclosed to the SEC on 2014-03-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| AKBA | BUY | 2014-12-01 | $13K | — | Filing → |
| GENZ | SELL | 2010-09-02 | $467K | — | Filing → |
| GENZ | SELL | 2010-05-26 | $24K | — | Filing → |